Etsuko Kumagai
Kumamoto University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Etsuko Kumagai.
Leukemia Research | 1986
Isao Sanada; Kiyonobu Nakada; Soei Furugen; Etsuko Kumagai; Kazunari Yamaguchi; Mitsuaki Yoshida; Kiyoshi Takatsuki
A cytogenetic study was performed on peripheral blood cells from a patient with smoldering adult T-cell leukemia (ATL). Four types of primary abnormal clones were found upon examination of a large number of karyotypically analysed cells cultured with and without phytohemagglutinin (PHA). However, human T-cell leukemia virus (HTLV) proviral DNA was confirmed to be monoclonal. This discrepancy can be explained by the hypothesis that these four primary abnormal clones were all derived from a leukemic clone with a normal karyotype and the same integration site of HTLV proviral DNA.
Acta Haematologica | 1988
Etsuko Kumagai; Takashi Kumagai; Shozo Tanoue; Norio Asou; Kazunari Yamaguchi; Hiroaki Okabe; Mitsuaki Yoshida; Kiyoshi Takatsuki
Serum levels of immunosuppressive acidic protein (IAP) were measured in patients with adult T-cell leukemia (ATL) in order to clarify its significance in this disease. The mean levels in patients with both acute (854 +/- 404 micrograms/ml) and chronic ATL (439 +/- 103 micrograms/ml) were significantly higher than in sera of healthy controls (367 +/- 104 micrograms/ml). However, mean levels in patients with smoldering ATL, healthy T-cell lymphotropic virus type 1 (HTLV-1) carriers and healthy controls showed no differences. Levels in crisis in chronic and smoldering ATL were similar to those in patients with acute ATL. Serial measurements of serum IAP in a number of patients revealed that the levels reflected each patients clinical course, suggesting a potential for use in evaluating the effects of chemotherapy.
AMB Express | 2011
Etsuko Kumagai; Masato Tominaga; Shinji Harada
To determine the sensitivities to low electrical potential of human immunodeficiency virus type 1 (HIV-1) and its target cells, HIV-1 and MAGIC-5 cells were directly stimulated with a constant direct current potential of 1.0 V (vs. Ag/AgCl). HIV-1 was incubated for 3 h at 37°C on a poly-L-lysine-coated indium-tin oxide electrode, and then stimulated by an electrical potential. MAGIC-5 cells were seeded onto the electrically stimulated HIV-1 and cultured for 3 days at 37°C. HIV-1-infected cells were measured by multinuclear activation via a galactosidase indicator assay. MAGIC-5 cells were also stimulated by an electrical potential of 1.0 V; cell damage, proliferation and apoptosis were evaluated by trypan blue staining, cell counting and in situ apoptosis detection, respectively. HIV-1 was found to be damaged to a greater extent by electrical stimulation than the cells. In particular, after application of a 1.0-V potential for 3 min, HIV-1LAI and HIV-1KMT infection were inhibited by about 90%, but changes in cell damage, proliferation and apoptosis were virtually undetectable. These results suggested that HIV-1 is significantly more susceptible to low electrical potential than cells. This finding could form the basis of a novel therapeutic strategy against HIV-1 infection.
Journal of Radiation Research | 1990
Etsuko Kumagai; Ryuji Tanaka; Takashi Kumagai; Mitsukazu Onomichi; Shozo Sawada
Hematological Oncology | 2006
Isao Sanada; Toshinori Ishii; Masao Matsuoka; Etsuko Kumagai; Hiromichi Nishimura; Kazunari Yamaguchi; Kiyoshi Takatsuki
Applied Microbiology and Biotechnology | 2003
Masato Tominaga; Etsuko Kumagai; Shinji Harada
Applied Microbiology and Biotechnology | 2004
Etsuko Kumagai; Masato Tominaga; Shinji Harada
Journal of Biotechnology | 2007
Masato Tominaga; Shouichiro Nagaishi; Maiko Kirihara; Etsuko Kumagai; Shinji Harada; Isao Taniguchi
Journal of Radiation Research | 1988
Etsuko Kumagai; Ryuji Tanaka; Takashi Kumagai; Yoshiharu Higashida; Mitsukazu Onomichi; Ikuo Nakamura; Shozo Tanoue; Takato Katsuki; Shozo Sawada
Applied Microbiology and Biotechnology | 2007
Etsuko Kumagai; Masato Tominaga; Shouichiro Nagaishi; Shinji Harada